House
19 párrafos sin cambios
Senate
Joint
Schedules
Committees
Bills
Law
Multimedia
Publications
Office of the Revisor of Statutes
Retrieve by number Document type Statutes Laws Rules Bills GO
Statutes
Laws
Rules
Court Rules
Constitution
Revisor's Office Revisor Intranet Attorney Drafting Areas Staff Directory Office Duties Publications Educational Seminars Employment Openings Order Publications
Search Law by Keyword
Bills
94th Legislature (2025 - 2026)
SF205
Introduction
1st Engrossment
SF 205
Introduction1st Engrossment - 94th Legislature (2025 - 2026)
Posted on 03/0711/2025 0209:3133 pa.m.
Bill Text Versions
13 párrafos sin cambios
Engrossments
Introduction PDF
Posted on 01/15/2025
1st Engrossment PDF
Posted on 03/10/2025
A bill for an act relating to health; prohibiting prior authorization of antineoplastic cancer treatment; amending Minnesota Statutes 2024, section 62M.07, subdivision 2.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
Section 1.
Minnesota Statutes 2024, section 62M.07, subdivision 2, is amended to read:
Subd. 2.
Prior authorization of certain services prohibited.
No utilization review organization, health plan company, or claims administrator may conduct or require prior authorization of:
(1) emergency confinement or an emergency service. The enrollee or the enrollee's authorized representative may be required to notify the health plan company, claims administrator, or utilization review organization as soon as reasonably possible after the beginning of the emergency confinement or emergency service;
(2) outpatient mental health treatment or outpatient substance use disorder treatment, except for treatment which is a medication. Prior authorizations required for medications used for outpatient mental health treatment or outpatient substance use disorder treatment must be processed according to section 62M.05, subdivision 3b, for initial determinations, and according to section 62M.06, subdivision 2, for appeals;
(3) antineoplastic cancer treatment that is consistent with guidelines of the National Comprehensive Cancer Network new text begin or nationally and internationally accepted standards of care new text end , deleted text begin except fordeleted text end new text begin including but not limited to new text end treatment deleted text begin whichdeleted text end new text begin that new text end is a medicationdeleted text begin . Prior authorizations required for medications used for antineoplastic cancer treatment must be processed according to section 62M.05, subdivision 3b, for initial determinations, and according to section 62M.06, subdivision 2, for appealsdeleted text end ;
(4) services that currently have a rating of A or B from the United States Preventive Services Task Force, immunizations recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, or preventive services and screenings provided to women as described in Code of Federal Regulations, title 45, section 147.130;
20 párrafos sin cambios
(5) pediatric hospice services provided by a hospice provider licensed under sections 144A.75 to 144A.755; and
(6) treatment delivered through a neonatal abstinence program operated by pediatric pain or palliative care subspecialists.
Clauses (2) to (6) are effective January 1, 2026, and apply to health benefit plans offered, sold, issued, or renewed on or after that date.
new text begin EFFECTIVE DATE. new text end
new text begin This section is effective January 1, 2027, and applies to health benefit plans offered, sold, issued, or renewed on or after that date. new text end
Historical Information
Employment/Internships
Visiting the Capitol
Accessibility
Frequently Asked Questions
Who Represents Me?
House Members
Senators
Contact a legislative librarian:
(651) 296-8338 or Email
Phone Numbers
Submit website comments
House News
Senate News
MyBills
Email Updates & RSS Feeds